跳至主要内容
临床试验/NL-OMON20771
NL-OMON20771
尚未招募
不适用

Magnetic Resonance Direct Thrombus Imaging for diagnostic management of suspected pelvic vein thrombosis during pregnancy

.A.0 个研究点目标入组 150 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Deep vein thrombosis
发起方
.A.
入组人数
150
状态
尚未招募
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Interventional

研究者

发起方
.A.

入排标准

入选标准

  • ?Pregnant women with suspected DVT, defined as i) new leg swelling or edema with onset in the last month or ii) new leg pain (buttock, groin, thigh or calf) with onset in the last month; pregnancy is defined as a positive pregnancy test and no sign of miscarriage
  • ?Onset of symptoms more than 24 hours but less than 10 days ago
  • ?Aged 18 years or older
  • ?Willing and able to give written informed consent

排除标准

  • ?Concomitant symptoms of suspected PE (chest pain or shortness of breath or syncope/pre\-syncope or unexplained tachycardia)
  • ?Therapeutic anticoagulant therapy more than 48 hours prior to inclusion (thrombosis prophylaxis is allowed)
  • ?MRI contra\-indication (including but not limited to a cardiac pacemaker or subcutaneous defibrillator; vascular clips in the cerebral vessels; metal splinter in the eye, a hearing aid that cannot be removed; a neurostimulator that cannot be removed; a hydrocephalus pump; claustrophobia)
  • ?Unable to perform MRI within 48 hours
  • ?A medical condition, associated illness or co\-morbid circumstances that precludes completion of the study procedures (MRI and 90\-day follow\-up assessment), including but not limited to life\-expectancy less than 3 months, inability to lie flat or morbid obesity preventing use of MR.
  • ?Any reperfusion therapy (e.g. thrombolysis, surgical clot removal) initiated for the current suspected VTE diagnosis applied before subjecting the patient to MRDTI.

结局指标

主要结局

未指定

相似试验